Evotec and Roche sign oncology partnership

Published: 1-Dec-2003
Sustainability


Evotec OAI and Roche are expanding their partnership through a medicinal chemistry collaboration to identify and develop a clinical lead candidate for one of RocheÕs cancer targets.

The two companies have worked together on the production of chemical libraries since 2001, with Evotec OAI supplying chemical compound libraries to Roche for use in drug discovery screening programmes. This agreement expands the partnership into a co-operative lead optimisation programme.

'Our partnership with Roche in discovery chemistry has been highly successful, and we are delighted that Roche has now also chosen us as their partner in the area of lead optimisation, which is a significant endorsement of our strategy of moving up the drug development value chain by integrating leading edge technologies to accelerate effective compound optimisation,' said Joern Aldag, president and ceo of Evotec.

  

See more

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

Read more
New SOLAR CEMNEX analyser offers advanced compliance and connectivity features

Trending Articles

  1. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  2. Ecolab and SCG sign MOU to enhance business competitiveness and drive ESG progress This 5-year MOU underscores how collaboration can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening cross-industry competitiveness
  3. Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold Gerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
  4. Five API manufacturing trends you need to know in 2025 How technology, sustainability and innovation are redefining pharmaceutical production
  5. GEA raises guidance following strong H1 performance Revised forecast reflects improved margins, robust order intake and efficiency gains

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Manufacturing

Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS

The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
Sustainability

Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold

Gerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
Sustainability

Ecolab and SCG sign MOU to enhance business competitiveness and drive ESG progress

This 5-year MOU underscores how collaboration can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening cross-industry competitiveness
Sustainability

Piramal Pharma publishes FY2025 sustainability report, outlining performance and decarbonization glidepath

Piramal Pharma Limited has released its fourth annual Sustainability Report for the financial year 2025, under the theme ‘Innovating Responsibly. Growing Sustainably.’
Sustainability

LOCTITE to showcase next generation of healthcare adhesive innovations

New biocompatible adhesives aim to improve safety, performance, and sustainability
Sustainability

IMCD receives upgraded ESG ratings from ISS ESG and Sustainalytics

Improvements reflect continued progress on emissions, transparency and ESG risk management
Subscribe now